Strategic Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Hold
375
0.15% 60
2025
Q4
$403K Hold
375
0.17% 59
2025
Q3
$286K Hold
375
0.13% 68
2025
Q2
$293K Hold
375
0.14% 66
2025
Q1
$310K Hold
375
0.16% 61
2024
Q4
$290K Buy
+375
New +$311K 0.15% 61

Other funds holding LLY

Strategic Financial Partners's LLY Position: Q1 2026 in Review

Strategic Financial Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 375 shares worth $345K. The position accounts for 0.15% of the portfolio, ranked #60.

Strategic Financial Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $403K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Strategic Financial Partners held 375 shares of Eli Lilly worth $345K as of Q1 2026.
  • Strategic Financial Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.15% of Strategic Financial Partners's portfolio in Q1 2026, its #60 holding.
  • Strategic Financial Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Strategic Financial Partners's Eli Lilly position peaked at $403K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Strategic Financial Partners's 13F filing for Q1 2026, filed 1 May 2026.